149 related articles for article (PubMed ID: 26416714)
1. Verification of WFA-Sialylated MUC1 as a Sensitive Biliary Biomarker for Human Biliary Tract Cancer.
Yamaguchi T; Yokoyama Y; Ebata T; Matsuda A; Kuno A; Ikehara Y; Shoda J; Narimatsu H; Nagino M
Ann Surg Oncol; 2016 Feb; 23(2):671-7. PubMed ID: 26416714
[TBL] [Abstract][Full Text] [Related]
2. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
[TBL] [Abstract][Full Text] [Related]
3. Serum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular Carcinoma.
Tamaki N; Kuno A; Matsuda A; Tsujikawa H; Yamazaki K; Yasui Y; Tsuchiya K; Nakanishi H; Itakura J; Korenaga M; Mizokami M; Kurosaki M; Sakamoto M; Narimatsu H; Izumi N
Sci Rep; 2017 Mar; 7(1):244. PubMed ID: 28325920
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.
Tang Z; Yang Y; Wang X; Meng W; Li X
BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476
[TBL] [Abstract][Full Text] [Related]
5. Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinoma.
Matsuda A; Kuno A; Matsuzaki H; Kawamoto T; Shikanai T; Nakanuma Y; Yamamoto M; Ohkohchi N; Ikehara Y; Shoda J; Hirabayashi J; Narimatsu H
J Proteomics; 2013 Jun; 85():1-11. PubMed ID: 23612463
[TBL] [Abstract][Full Text] [Related]
6. Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma.
Matsuda A; Kuno A; Kawamoto T; Matsuzaki H; Irimura T; Ikehara Y; Zen Y; Nakanuma Y; Yamamoto M; Ohkohchi N; Shoda J; Hirabayashi J; Narimatsu H
Hepatology; 2010 Jul; 52(1):174-82. PubMed ID: 20578261
[TBL] [Abstract][Full Text] [Related]
7. Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
Hagiwara K; Tobisawa Y; Kaya T; Kaneko T; Hatakeyama S; Mori K; Hashimoto Y; Koie T; Suda Y; Ohyama C; Yoneyama T
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134773
[No Abstract] [Full Text] [Related]
8. Lectin Microarray-Based Sero-Biomarker Verification Targeting Aberrant O-Linked Glycosylation on Mucin 1.
Matsuda A; Kuno A; Nakagawa T; Ikehara Y; Irimura T; Yamamoto M; Nakanuma Y; Miyoshi E; Nakamori S; Nakanishi H; Viwatthanasittiphong C; Srivatanakul P; Miwa M; Shoda J; Narimatsu H
Anal Chem; 2015 Jul; 87(14):7274-81. PubMed ID: 26091356
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in pancreatic ductal adenocarcinoma.
Waragai Y; Suzuki R; Takagi T; Sugimoto M; Asama H; Watanabe K; Kikuchi H; Hikichi T; Masamune A; Kang Y; Fleming JB; Ohira H
Pancreatology; 2016; 16(6):1044-1050. PubMed ID: 27665173
[TBL] [Abstract][Full Text] [Related]
10. A novel glycobiomarker, Wisteria floribunda agglutinin macrophage colony-stimulating factor receptor, for predicting carcinogenesis of liver cirrhosis.
Iio E; Ocho M; Togayachi A; Nojima M; Kuno A; Ikehara Y; Hasegawa I; Yatsuhashi H; Yamasaki K; Shimada N; Ide T; Shinkai N; Nojiri S; Fujiwara K; Joh T; Mizokami M; Narimatsu H; Tanaka Y
Int J Cancer; 2016 Mar; 138(6):1462-71. PubMed ID: 26437001
[TBL] [Abstract][Full Text] [Related]
11. N-glycan structures of Wisteria floribunda agglutinin-positive Mac2 binding protein in the serum of patients with liver fibrosis†.
Noro E; Matsuda A; Kyoutou T; Sato T; Tomioka A; Nagai M; Sogabe M; Tsuruno C; Takahama Y; Kuno A; Tanaka Y; Kaji H; Narimatsu H
Glycobiology; 2021 Nov; 31(10):1268-1278. PubMed ID: 34192302
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma.
Fujiyoshi M; Kuno A; Gotoh M; Fukai M; Yokoo H; Kamachi H; Kamiyama T; Korenaga M; Mizokami M; Narimatsu H; Taketomi A;
J Gastroenterol; 2015 Nov; 50(11):1134-44. PubMed ID: 25773774
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in idiopathic pulmonary fibrosis.
Kono M; Nakamura Y; Oyama Y; Mori K; Hozumi H; Karayama M; Hashimoto D; Enomoto N; Fujisawa T; Inui N; Yamada M; Hamada E; Colby TV; Maekawa M; Suda T
Respir Med; 2016 Jun; 115():46-52. PubMed ID: 27215503
[TBL] [Abstract][Full Text] [Related]
14. Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis.
Umemura T; Joshita S; Sekiguchi T; Usami Y; Shibata S; Kimura T; Komatsu M; Matsumoto A; Ota M; Tanaka E
Am J Gastroenterol; 2015 Jun; 110(6):857-64. PubMed ID: 25916223
[TBL] [Abstract][Full Text] [Related]
15. Increased serum Wisteria floribunda agglutinin positive Mac-2 binding protein (Mac-2 binding protein glycosylation isomer) in chronic heart failure: a pilot study.
Okada A; Kanzaki H; Hamatani Y; Takashio S; Takahama H; Amaki M; Hasegawa T; Sugano Y; Yasuda S; Anzai T
Heart Vessels; 2018 Apr; 33(4):385-392. PubMed ID: 29098408
[TBL] [Abstract][Full Text] [Related]
16. Wisteria floribunda agglutinin positive glycobiomarkers: a unique lectin as a serum biomarker probe in various diseases.
Narimatsu H; Sato T
Expert Rev Proteomics; 2018 Feb; 15(2):183-190. PubMed ID: 29265940
[TBL] [Abstract][Full Text] [Related]
17. Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis.
Hasegawa K; Takata R; Nishikawa H; Enomoto H; Ishii A; Iwata Y; Miyamoto Y; Ishii N; Yuri Y; Nakano C; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626413
[TBL] [Abstract][Full Text] [Related]
18. Application of a glycoproteomics-based biomarker development method: alteration in glycan structure on colony stimulating factor 1 receptor as a possible glycobiomarker candidate for evaluation of liver cirrhosis.
Ocho M; Togayachi A; Iio E; Kaji H; Kuno A; Sogabe M; Korenaga M; Gotoh M; Tanaka Y; Ikehara Y; Mizokami M; Narimatsu H
J Proteome Res; 2014 Mar; 13(3):1428-37. PubMed ID: 24422531
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease.
Zabron AA; Horneffer-van der Sluis VM; Wadsworth CA; Laird F; Gierula M; Thillainayagam AV; Vlavianos P; Westaby D; Taylor-Robinson SD; Edwards RJ; Khan SA
Am J Gastroenterol; 2011 Sep; 106(9):1711-7. PubMed ID: 21670771
[TBL] [Abstract][Full Text] [Related]
20. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein evaluates liver function and predicts prognosis in liver cirrhosis.
Xu WP; Wang ZR; Zou X; Zhao C; Wang R; Shi PM; Yuan ZL; Yang F; Zeng X; Wang PQ; Sultan S; Zhang Y; Xie WF
J Dig Dis; 2018 Apr; 19(4):242-253. PubMed ID: 29607614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
